SAFETY TESTING OF REMERGENT™ SKINCARE PRODUCTS.

Remergent products are manufactured by AGI Dermatics under rigorous quality control procedures to ensure safety. Testing begins with the important functional ingredients, which are subjected to the most stringent tests in the industry. The finished Remergent products were subjected to safety testing by two in vitro tests to screen for dermal and ocular irritancy, and clinical testing on hundreds of human subjects by Repeated Insult Patch Tests to test for irritancy and allergic sensitization. All products were found to be either “moderate to mild”, “very mild”, or “non-irritating” to the skin by the EpiDerm™ in vitro model, and “non-irritating” to the eye by the EpiOcular™ in vitro model. All Remergent products were non-reactive on human subjects by the Patch tests. Remergent products have little or no potential for irritancy or sensitization.